+ POLICY — Keir Starmer has said ministers should be able to “look every parent in the eye” and pledge that tech can cre…− POLICY — Artificial intelligence poses a “Hiroshima”-style risk to humanity if governments do not agree to curb how it…− CLIMATE — Artificial intelligence is often associated with ludicrous amounts of electricity, and therefore planet-heati…− EDUCATION — While many schools in England have banned smartphones, in Estonia – regarded as the new European education po…− EDUCATION — In a Cambridge classroom, Joseph, 10, trained his AI model to discern between drawings of apples and drawings…− EDUCATION — OpenAI CEO Sam Altman recently told a US podcast that if he was graduating today, “I would feel like the luck…+ EDUCATION — I disagree with the decision of lecturers to use artificial intelligence to create teaching materials (‘We co…− BUSINESS — Americans are growing worried about what artificial intelligence portends for their futures. Eight in 10 Amer…
TruaceTracing the truth around AISunday, July 12, 2026
Subscribe
Health·P Space·Evidence-backed problem·Published 2026-07-12

Reveal linq: FDA malfunction report involving AI

The FDA received a malfunction report involving Reveal linq, made by Medtronic europe sarl. It was reported that the implantable cardiac monitor (icm) experienced false pause episodes due to undersensing. it was reported that representative stated the customer is concerned that the artificial intelligence (ai) algorithm adjudicated some pause episodes as false when they determined to be true. the icm remains in the patient. no patient complications have been reported as a result of this event.

TRV-2026-0041Official statisticsPermanent record — cite & verify
Reveal linq: FDA malfunction report involving AI

"Medical laboratories and clinics in Kinwat" by Mouryan, CC BY-SA 4.0.

Main points
  • Device: Reveal linq; manufacturer: Medtronic europe sarl.
  • FDA report type: Malfunction.
  • An adverse-event report is a safety signal, not proof that the device caused the event.
Problem

An FDA adverse-event report linked Reveal linq to an AI-related malfunction; the report requires investigation and does not by itself establish causality.

The rundown

It was reported that the implantable cardiac monitor (icm) experienced false pause episodes due to undersensing. it was reported that representative stated the customer is concerned that the artificial intelligence (ai) algorithm adjudicated some pause episodes as false when they determined to be true. the icm remains in the patient. no patient complications have been reported as a result of this event.

The report is part of FDA’s MAUDE surveillance data. It should be read as a signal for follow-up, not a clinical conclusion or a verified incidence rate.

Sources

The debate